Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 nov 2007 - 14:00
Statutaire naam
Crucell N.V.
Titel
Crucell Sells Stake in Pevion Biotech
Bericht
Leiden, The Netherlands, 12 November 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced that Berna Biotech AG, its wholly owned subsidiary, has sold all the 2.9 million shares it owned in Pevion Biotech Ltd, Bern (Switzerland) to other shareholders of Pevion Biotech. This number of shares represents 36 percent of Pevion Biotech’s capital and results in net proceeds for Crucell of approximately CHF 10 million (€ 6 million).
“This transaction is further proof that we are committed to focus on the strengths of our core business”, said Crucell’s Chief Financial Officer, Leonard Kruimer.
Gerelateerde downloads
Datum laatste update: 07 oktober 2024